GeneFerm Biotechnology Co., Ltd. (1796.TWO)

TWD 46.65

(0.43%)

EBITDA Summary of GeneFerm Biotechnology Co., Ltd.

  • GeneFerm Biotechnology Co., Ltd.'s latest annual EBITDA in 2023 was 231.09 Million TWD , up 41.22% from previous year.
  • GeneFerm Biotechnology Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 11.95 Million TWD , up 4.34% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported an annual EBITDA of 163.34 Million TWD in 2022, up 31.19% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported an annual EBITDA of 124.51 Million TWD in 2021, up 112.53% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly EBITDA of 11.95 Million TWD for 2024 Q2, up 4.34% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly EBITDA of 79.54 Million TWD for 2023 Q2, up 41.33% from previous quarter.

Annual EBITDA Chart of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Created with Highcharts 11.1.0YearsEBITDA20192019.520202020.520212021.520222022.520230 TWD50000000 TWD100000000 TWD150000000 TWD200000000 TWD250000000 TWD300000000 TWD

Historical Annual EBITDA of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 231.09 Million TWD 41.22%
2022 163.34 Million TWD 31.19%
2021 124.51 Million TWD 112.53%
2020 58.58 Million TWD 305.94%
2019 14.64 Million TWD 0.0%

Peer EBITDA Comparison of GeneFerm Biotechnology Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD -12.843%
Easywell Biomedicals, Inc. -85.5 Million TWD 370.282%
TTY Biopharm Company Limited 1.52 Billion TWD 84.84%
Synmosa Biopharma Corporation 1 Billion TWD 77.091%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 60.357%
Center Laboratories, Inc. -175.17 Million TWD 231.926%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -644.312%
Orient Pharma Co., Ltd. 172.39 Million TWD -34.049%
InnoPharmax Inc. -62.12 Million TWD 472.012%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -82.426%
Excelsior Biopharma Inc. -29.36 Million TWD 886.864%
DV Biomed Co., Ltd. 407.64 Million TWD 43.309%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 125.335%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 71.213%
UniPharma Co., Ltd. -16.25 Million TWD 1521.767%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -75.991%
Alar Pharmaceuticals Inc. 394.52 Million TWD 41.424%
Winston Medical Supply Co., Ltd. 228.32 Million TWD -1.213%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 692.033%
Bioray Biotech Co., Ltd 12.13 Million TWD -1804.359%
TSH Biopharm Corporation Limited 99.35 Million TWD -132.606%